The Week in Review #51
Questions & Answers
Q: Is there any reason for the CytomX stock selloff that occurred in early May?
In order to answer this question we need to explain CytomX’s (CTMX) Probody therapeutics. These novel treatments are designed to remain inactive until they are activated only . . .
This content is for paid subscribers.
Prohost Letters May 27, 2020